IMCC IM Cannabis Corp. logo

IMCC IM Cannabis Corp.

Healthcare
$0.24+2.98%ClosedMarket Cap: $746,679

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

4.72

P/S

0.45

EV/EBITDA

-80.47

DCF Value

$-12.16

FCF Yield

-1.4%

Div Yield

0.0%

Margins & Returns

Gross Margin

24.8%

Operating Margin

-51.6%

Net Margin

-3.0%

ROE

-24.4%

ROA

-2.8%

ROIC

-95.0%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$6.3M$-1.7M$
Q4 null$11.2M$-5.5M$
FY null$54.7M$-11.3M$
Q3 null$13.9M$-3.7M$

Analyst Ratings

View All

Consensus

Hold

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

0 Strong Buy0 Buy1 Hold0 Sell0 Strong Sell

Company Info

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

IL

Exchange

Beta

2.02

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.

Peers